ArticlePakistan journal of medical sciences2025
Clinical efficacy of traditional Chinese medicine compound on patients with knee osteoarthritis and its impact on inflammatory cytokine levels.
Article in Pakistan journal of medical sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To investigate the clinical efficacy of traditional Chinese medicine (TCM) compound in the treatment of knee osteoarthritis (KOA) and its impact on inflammatory cytokine levels. Methods: A retrospective analysis was conducted on the medical records of 80 KOA patients admitted to Hebei Province Hospital of Chinese Medicine from January 2021 to January 2023. The patients were divided into an observation group and a control group based on different treatment methods (n=40 each group). The visual analogue scale (VAS) was adopted to assess patients' pain level, and the Lysholm score was used to evaluate knee joint function, and the clinical outcomes of the two groups were compared. Results: After treatment, both groups exhibited a significant decrease in VAS scores, with the observation group showing a more substantial reduction(P<0.05). The Lysholm scores of both groups were significantly higher after treatment than before treatment (P<0.05). Serum levels of CRP, IL-6, and TNF-α decreased significantly in both groups after treatment, with the observation group showing a more pronounced reduction (P<0.05). The ADL scores for both advanced and basic abilities improved significantly post-treatment in both groups, with the observation group demonstrating a statistically significant greater improvement (P<0.05). The treatment efficacy for the observation group was 92.50%, which was significantly higher than the control group's rate of 77.50% (χ²=4.114, P<0.05). Conclusion: Traditional Chinese Medicine(TCM) compound therapy for KOA can significantly alleviate patients' pain, reduce the expression of inflammatory factors in serum, enhance knee joint function, and improve patients' quality of life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.